Dorsay Sadeghian
Overview
Explore the profile of Dorsay Sadeghian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parikh K, Harris F, Karagouga G, Schrandt A, Mandrekar J, Johnson S, et al.
JTO Clin Res Rep
. 2024 Dec;
5(12):100692.
PMID: 39735890
Introduction: The spatially complex nature of mesothelioma and interventions like pleurodesis, surgery, and radiation often complicate imaging-based assessment. Further, cell-free DNA (cfDNA) based monitoring strategies are inadequate for mesothelioma, given...
2.
Nishiwaki N, Sugiura K, Suzuki K, Li A, Tapia Contreras C, Efe G, et al.
Cell Mol Gastroenterol Hepatol
. 2024 Dec;
:101442.
PMID: 39694413
No abstract available.
3.
Li A, Sugiura K, Nishiwaki N, Suzuki K, Sadeghian D, Zhao J, et al.
Dev Cell
. 2024 Aug;
59(22):3025-3042.e7.
PMID: 39178842
Acinar cells have been proposed as a cell-of-origin for pancreatic ductal adenocarcinoma (PDAC) after undergoing acinar-to-ductal metaplasia (ADM). ADM can be triggered by pancreatitis, causing acinar cells to de-differentiate to...
4.
Gagnon M, Penheiter A, Harris F, Sadeghian D, Johnson S, Karagouga G, et al.
Blood Cancer J
. 2023 Dec;
13(1):190.
PMID: 38114462
No abstract available.
5.
El Khoury L, Lin W, Smadbeck J, Barrett M, Sadeghian D, McCune A, et al.
Epigenomics
. 2023 May;
15(5):283-292.
PMID: 37212177
This work examines differences in chromatin accessibility, methylation, and response to DNA hypomethylating agents between mismatch repair-deficient and non-mismatch repair-deficient endometrial cancer. Next-generation sequencing of a stage 1B, grade 2...
6.
Sadeghian D, Saffar H, Mahdavi Sharif P, Soleimani V, Jahanbin B
Diagn Pathol
. 2022 Feb;
17(1):24.
PMID: 35125121
Background: Currently, breast cancers are divided into four major molecular subtypes. The distinction between the luminal A and luminal B subtypes is mainly based on the cellular proliferation indices and...
7.
Sadeghian D, Azmoudeh-Ardalan F, Dashti-Khavidaki S, Fakhar N
Iran J Pathol
. 2020 Sep;
15(4):338-341.
PMID: 32944048
Occurrence of hepatotoxicity following prescription of etanercept, a tumor necrosis factor-alpha (TNF-α) antagonist, is a relatively well-known issue. On the other hand, acute hepatic failure which could lead to liver...